Amanote Research

Amanote Research

    RegisterSign In

Use of Injectable Spasticity Management Agents in a Cancer Center

Supportive Care in Cancer - Germany
doi 10.1007/s00520-012-1651-0
Full Text
Open PDF
Abstract

Available in full text

Categories
Oncology
Date

November 11, 2012

Authors
Jack FuCarolina GutiérrezEduardo BrueraYing GuoShana Palla
Publisher

Springer Science and Business Media LLC


Related search

Clinical Management of Spasticity

Journal of Neurology, Neurosurgery and Psychiatry
PsychiatryMental HealthNeurologySurgery
2005English

Management of Childhood Spasticity: A Neurosurgical Perspective

Pediatric Annals
Child HealthPediatricsPerinatology
2006English

Self-Injectable Epinephrine Prescription Trends in a Tertiary Referral Center

Journal of Allergy and Clinical Immunology
AllergyImmunology
2017English

Spasticity: Mechanism, Measurement, Management

Journal of Neurology, Neurosurgery and Psychiatry
PsychiatryMental HealthNeurologySurgery
1970English

Novel Intraprostatic Injectable Agents in the Treatment of BPH

2019English

Use of Port-A-Cath in Cancer Patients: A Single-Center Experience

Journal of Infection in Developing Countries
MedicineVirologyParasitologyInfectious DiseasesMicrobiology
2014English

Dynamics of Injectable Contraceptive Use in India

2018English

Management and Treatment of Post Stroke Spasticity

The Japanese Journal of Rehabilitation Medicine
2018English

Implications of Cardiovascular Outcome Trials With Injectable Antidiabetic Agents

Journal of Diabetes
EndocrinologyMetabolismDiabetes
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy